-
Medical journals
- Career
Palmo-plantar Erythrodysesthesia caused by Liposome-encapsulated Doxorubicin
Authors: V. Miňovská
Authors‘ workplace: Dermatovenerologická klinika 1. LF UK, VFN Prahapřednosta doc. MUDr. J. Štork, CSc.
Published in: Čes-slov Derm, , 2003, No. 4, p. 159-161
Category:
Overview
Palmo-plantar erythrodysesthesia (PPE) is a relatively frequent manifestation of the side-effectsof chemotherapy in the skin. It has a clear-out clinical picture, non-specific histology and unclearpathogenesis. Its course in patients often calls for modification and sometimes interruption ofotherwise effective chemotherapy. There is no specific treatment, however, there has been describedthe possible application of certain drugs in cases of chemotherapeutics with which the risk of PPEis most often connected (doxorubicin, cytarabin, docetaxel, fluorouracil). The author describesa clinical case of PPE upon application of liposome-encapsulated doxorubicin in a patient sufferingfrom ovarial carcinoma.
Key words:
chemotherapy - doxorubicin - side-effects - erythrodysesthesia
Labels
Dermatology & STDs Paediatric dermatology & STDs
Article was published inCzech-Slovak Dermatology
2003 Issue 4-
All articles in this issue
- Use of the S-100 Protein as a Tumour Marker in Malignant Melanoma
- Palmo-plantar Erythrodysesthesia caused by Liposome-encapsulated Doxorubicin
- Granular Parakeratosis
- Malignant Eccrine Poroma (Eccrine Porocarcinoma)
- Digitalized Dermatoscopy in Investigation of Pigmented Skin Lesions (PreliminaryClinical Experience)
- Fibrous Nodules in Lyme Borreliosis
- Czech-Slovak Dermatology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Granular Parakeratosis
- Palmo-plantar Erythrodysesthesia caused by Liposome-encapsulated Doxorubicin
- Malignant Eccrine Poroma (Eccrine Porocarcinoma)
- Fibrous Nodules in Lyme Borreliosis
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career